The report published by the World Health Organization (WHO) stated that although nearly five years have passed since the first notification of COVID-19, progress in addressing critical deficiencies in the prevention of healthcare-associated infections (HAIs) is slow.

These measures are also among the ‘most cost-effective solutions’ for reducing the risk of antimicrobial resistance (AMR) in healthcare settings.





